|
|
Volumn 62, Issue 7, 2006, Pages 587-588
|
|
Effect of tofisopam on the single-oral-dose pharmacokinetics and pharmacodynamics of the cyp3a4 probe drug alprazolam [2]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPRAZOLAM;
CYTOCHROME P450 3A4;
PLACEBO;
TOFISOPAM;
ANALYSIS OF VARIANCE;
AREA UNDER THE CURVE;
CAPILLARY GAS CHROMATOGRAPHY;
CLINICAL TRIAL;
CONFIDENCE INTERVAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROSSOVER PROCEDURE;
DOUBLE BLIND PROCEDURE;
DRUG BLOOD LEVEL;
DRUG CLEARANCE;
DRUG ELIMINATION;
DRUG HALF LIFE;
ENZYME ACTIVITY;
ENZYME INHIBITION;
EVALUATION;
HUMAN;
HUMAN EXPERIMENT;
HUNGARY;
LETTER;
MALE;
MASS SPECTROMETRY;
NORMAL HUMAN;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
VOLUNTEER;
ADMINISTRATION, ORAL;
ALPRAZOLAM;
ANTI-ANXIETY AGENTS;
ANTIDEPRESSIVE AGENTS;
AREA UNDER CURVE;
BENZODIAZEPINES;
CYTOCHROME P-450 CYP3A;
CYTOCHROME P-450 ENZYME SYSTEM;
DRUG INTERACTIONS;
HUMANS;
LIVER;
MALE;
|
|
EID: 33745713162
PISSN: 00316970
EISSN: None
Source Type: Journal
DOI: 10.1007/s00228-006-0160-9 Document Type: Letter |
|
Times cited : (1)
|
|
References (2)
|
